Loading…
Source: SEBI
As stated in the prospectus. Standalone vs consolidated is kept as filed.
March 31, 2026 · Restated
Lakhs
March 31, 2025 · Restated
Lakhs
March 31, 2024 · Restated
Lakhs
The company has shown an upward trend in revenue from operations, with significant contributions from key seed products. However, it has also faced negative cash flows in previous fiscal years, indicating potential volatility in financial performance.
Vardaan Biotech Limited has reported negative cash flows from operating activities in certain fiscal years, raising concerns about its cash flow quality and operational efficiency.